除上述内容变更外，公司注册地址、网址、联系方式、电子邮箱等其他信息 均保持不变。上述变更自本公告披露之日起正式启用，敬请广大投资者知悉。 特此公告。 万向新元科技股份有限公司董事会 2025年 5月 8 日 万向新元科技股份有限公司 关于公司办公地址变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 万向新元科技股份有限公司（以下简称"公司"）因经营发展需要，于近日 完成新办公场所的搬迁工作，现将有关变更事项公告如下： | 项目 | 变更前 | 变更后 | | --- | --- | --- | | 办公地址 | 北京市海淀区学清路8号科技财富中心 | 北京市朝阳区望京东园四区11号楼41 | | | B栋12层 | 层4101室 | | 邮政编码 | 100192 | 100102 | 因公司办公场所变更，原定于2025年5月21日召开的2024年年度股东会现场会 议地址变更为北京市朝阳区望京东园四区11号楼41层4101室。 证券代码：300472 证券简称：新元科技 公告编号：临-2025-060 ...

Da Hua Certified PublicAccountants（Special General Partnership） 万向新元科技股份有限公司 审计报告及财务报表 万向新元科技股份有限公司 审计报告 大华审字[2025]0011009249 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) 大华会计师事务所（特殊普通合伙） 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话：86 (10) 5835 0011 传真：86 (10) 5835 0006 www.dahua-cpa.com 审 计 报 告 大华审字[2025]0011009249号 万向新元科技股份有限公司全体股东： 一、无法表示意见 我们审计了万向新元科技股份有限公司(以下简称新元科技)财 务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公 司股东权益变动表以及相关财务报表附注。 我们不对后附的财务报表发表审计意见。由于"形成无法表示意 见的基础"部分所述事项的重要性，我们无法获取充分、适当的审计 证 ...

证券代码：300472 证券简称：新元科技 公告编号：临-2025-059 关于召开 2024 年年度股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 根据万向新元科技股份有限公司（以下简称"公司"）第五届董事会第八 次会议决议，公司定于2025年5月21日召开2024年年度股东会，现将有关事项通 知如下： 一、召开本次股东会的基本情况 1、股东会届次：2024年年度股东会 2、股东会召集人：公司董事会 3、会议召开的合法、合规性：公司第五届董事会第八次会议审议通过了 《关于提请召开公司2024年年度股东会的议案》，本次股东会的召开符合法律 法规、规范性文件和《公司章程》的规定。 4、股权登记日：2025年5月15日（星期四） 5、会议召开日期、时间： （1）现场会议召开时间：2025年5月21日（星期三）14:00 万向新元科技股份有限公司 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为：2025年5月21日的交易时间，即9:15—9：25，9：30—11:30和13:00— 15:00；通过深圳证券交易所互联网投票系 ...

Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]

新元科技于2025年3月27日收到中国证监会立案告知书，因涉嫌存在信息披露违法违规，中国证监会决 定立案调查，目前调查结果尚未出来。 公告显示，新元科技针对上述调查相关事项进行了自查并将发现的前期差错采用追溯重述法进行更正， 因此调减2023年度营业收入1.05亿元、营业成本8814.84万元，调减2023年末存货5827万元，调减2022年 度营业收入1.67亿元、营业成本1.57亿元，调减2022年末存货3195.72万元，同时对应收账款及坏账准备 等进行追溯调整。 本报记者 曹琦 4月30日，万向新元科技股份有限公司（以下简称"新元科技"）公告，公司股票于4月30日开市起停牌一 天，并于5月6日开市起复牌，复牌后股票简称将由"新元科技"变更为"*ST新元"。 新元科技之所以被实施退市风险警示，主要是因为大华会计师事务所（特殊普通合伙）（以下简称"大 华"）对公司2024年度财务报表出具了无法表示意见的审计报告、对公司2024年度内部控制出具了否定 意见的审计报告、公司已经连续三年扣非净利润均为负值。 调查结果尚未出来 大华方面表示，截至审计报告日，上述立案调查尚无结论性意见，无法核实会计差错更正的依据， ...

Core Viewpoint - New Yuan Technology (300472.SZ) announced that some directors cannot guarantee the authenticity, accuracy, and completeness of the 2024 annual report and related proposals due to significant issues identified in financial data and governance [1] Group 1: Company Governance and Financial Reporting - Director Zhang Guanghua voted against the proposals related to the 2024 annual report, 2025 Q1 report, prior accounting errors correction, and credit impairment losses for 2024, citing concerns over financial data integrity [1] - The company has received a notice of investigation from the China Securities Regulatory Commission (CSRC), indicating potential regulatory scrutiny [1] - Deloitte's audit report for the company was issued with a disclaimer of opinion, and the internal control audit report received a negative opinion, highlighting major issues in financial data and governance [1]

Financial Performance - The company's revenue for Q1 2025 was ¥3,808,294.43, a decrease of 94.74% compared to ¥72,430,778.91 in the same period last year[5] - The net loss attributable to shareholders was ¥17,228,373.34, representing a 21.73% increase in loss compared to ¥14,152,746.41 in the previous year[5] - The net loss for the current period was CNY 18,168,945.29, compared to a net loss of CNY 15,821,710.75 in the previous period, reflecting an increase in losses of approximately 21.5%[17] - The total comprehensive income for the period was -18,168,945.29, compared to -15,821,710.75 in the previous period, indicating a decline[18] - Basic and diluted earnings per share were both -0.06, compared to -0.05 in the previous period, indicating a slight deterioration[18] Cash Flow - The net cash flow from operating activities improved by 82.55%, amounting to -¥7,553,186.07, compared to -¥43,285,466.92 in the same period last year[5] - The net cash flow from operating activities was -7,553,186.07, a significant improvement from -43,285,466.92 in the previous period[21] - Cash inflows from operating activities totaled 23,481,968.27, down from 69,076,479.83 in the previous period, reflecting a decrease of approximately 66%[20] - Cash outflows from operating activities were 31,035,154.34, compared to 112,361,946.75 in the previous period, showing a reduction of about 72%[21] - The net cash flow from financing activities was 13,980,169.07, a turnaround from -23,497,004.14 in the previous period[21] - The company received cash from borrowings amounting to 14,420,182.50, significantly lower than 90,510,000.00 in the previous period[21] - The cash received from other operating activities was 2,846,623.42, down from 10,753,488.00 in the previous period, reflecting a decrease of approximately 73%[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,028,391,761.07, reflecting a 1.53% increase from ¥1,012,848,646.10 at the end of the previous year[5] - Total current assets reached CNY 543,453,034.18, up from CNY 508,921,588.20, which is an increase of about 6.8%[14] - Total liabilities increased to CNY 1,044,365,992.53 from CNY 1,009,709,151.77, reflecting a rise of approximately 3.4%[15] - The company's total assets amounted to CNY 1,028,391,761.07, compared to CNY 1,012,848,646.10, indicating a slight increase of about 1.5%[15] Shareholder Information - The equity attributable to shareholders decreased by 98.62%, down to ¥8,527,155.90 from ¥616,422,595.56 at the end of the previous year[5] - The total number of ordinary shareholders at the end of the reporting period was 24,840[10] Operational Efficiency - The decline in revenue was primarily due to the company's failure to meet customer acquisition expectations in the market[7] - Total operating costs amounted to CNY 21,765,497.67, down from CNY 97,045,326.65, indicating a reduction of about 77.6%[16] - Research and development expenses were CNY 4,461,648.71, down from CNY 13,828,524.53, representing a decrease of approximately 67.7%[17] - Accounts receivable increased to CNY 229,573,097.16 from CNY 221,400,119.11, showing a growth of about 3.9%[14] - Inventory rose to CNY 193,632,766.38 from CNY 181,491,469.40, marking an increase of approximately 6.7%[14] - The company reported non-recurring gains of ¥297,267.34 during the period, primarily from non-current asset disposals and other income[6] Other Information - The weighted average return on equity was -95.31%, a significant decline of 92.29% from -3.02% in the previous year[5] - The ending cash and cash equivalents balance was 9,789,953.57, down from 18,006,814.88 in the previous period[21] - The company did not execute any mergers or acquisitions during the reporting period[22]

证券代码：300472 证券简称：新元科技 公告编号：临-2025-053 万向新元科技股份有限公司 关于部分董事无法保证 2024 年年度报告、2025 年一季度报告、 前期会计差错更正及追溯调整、2024 年度计提信用减值损失及资 产减值损失的议案真实、准确、完整的说明公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 万向新元科技股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日召开第 五届董事会第八次会议，审议《关于公司<2024 年年度报告>及其摘要的议案》，《关 于前期会计差错更正及追溯调整的议案》，《关于公司<2025 年第一季度报告>的议 案》，《2024 年度计提信用减值损失及资产减值损失的议案》。本人张光华作为公 司董事对上述议案投反对票，无法保证公司相关财务数据的真实、准确、完整。现 将张光华本人无法保证相关事项说明如下： 投资，注意投资风险。 特此公告。 万向新元科技股份有限公司 董事会 2025 年 4 月 29 日 通过与年度审计会计师、财务人员、公司员工、公司债权人等了解相关情况， 本人勤勉尽责、严格依法依规，力 ...

2024 年度财务决算报告 公司 2024 年度财务报表已经大华会计师事务所(特殊普通合伙)审计，并出具了无法 表述意见的审计报告。 万向新元科技股份有限公司 现将公司的财务决算情况汇报如下： 一、报告期末公司资产负债及所有者权益情况（单位：万元） | 项目 | 2024 年 12 月 | 31 日 | 2023 年 | 12 月 31 | 日 | 同比增长率 | | --- | --- | --- | --- | --- | --- | --- | | 流动资产 | | 50,892.16 | | 75,575.63 | | -32.66% | | 资产总额 | | 101,284.86 | | 142,281.81 | | -28.81% | | 流动负债 | | 86,276.00 | | 77,584.50 | | 11.20% | | 负债总额 | | 100,970.92 | | 97,915.98 | | 3.12% | | 所有者权益 | | 313.95 | | 44,365.83 | | -99.29% | 说明： 1、报告期内流动资产大幅下降减少主要系应收账款减少所致。 2、报告期内所有 ...

证券代码：300472 证券简称：新元科技 公告编号：临-2025-044 万向新元科技股份有限公司 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 万向新元科技股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日召开 第五届董事会第八次会议和第五届监事会第五次会议，审议通过了《关于会计政 策变更的议案》，根据财政部发布的《企业数据资源相关会计处理暂行规定》（财 会〔2023〕11 号）和《企业会计准则解释第 18 号》（财会〔2024〕24 号）的要 求变更会计政策。本次会计政策变更是公司根据法律法规和国家统一的会计制度 的要求进行的变更，不会对公司财务状况、经营成果和现金流量产生重大影响。 根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》等有关规定，公司本次会计政策变更无需提交股东会审议。现将具体情 况公告如下： 一、会计政策变更概述 1、变更的原因 本公司自 2024 年 1 月 1 日起执行企业数据资源相关会计处理暂行规定（以 下简称"暂行规定"）。2024 年 12 月 6 日【（ ...